YOUNG THERAPEUTICS, LLC
Philadelphia, PA · Biotech · Defunct
PKCε and PKCβII inhibitor molecules (YT-002 and YT-004) for cardioprotection in myocardial ischemia-reperfusion injury
youngtherapeutics.com →- Grants
- $3.9M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 0 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · The effects of protein kinase C epsilon peptide inhibitor (YT-001) in warm murine kidney ischemia-reperfusion | $351,000 | |
| Federal grant | Department of Health and Human Services · Phase I · The effects of protein kinase C epsilon peptide inhibitor (YT-001) in warm murine kidney ischemia-reperfusion | $51,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Young, Lindon H | $560,261 | |
| Federal grant | Department of Health and Human Services · Phase II · Minimizing myocardial damage and loss of cardiac function post myocardial infarction using Targeted PKC inhibitors 002 and 004. | $1,488,899 | |
| Federal grant | Department of Health and Human Services · Phase II · Minimizing myocardial damage and loss of cardiac function post myocardial infarction using Targeted PKC inhibitors 002 and 004. | $1,488,899 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2636 | Rapport Therapeutics | — | — |
| 2637 | COSMICA Inc. | — | $200K |
| 2638 | Ayala Pharmaceuticals, Inc. | — | $45M |
| 2639 | YOUNG THERAPEUTICS, LLC | — | — |
| 2640 | Avant Sciences, Inc. | — | $175K |
| 2641 | Renova Therapeutics, Inc. | — | $167K |
| 2642 | BIONANOTECH LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Protein Kinase C Modulatorsapplication
- Protein Kinase C Modulatorsapplication
- Protein Kinase C Modulatorsapplication
- Protein Kinase C Modulatorsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.